129 related articles for article (PubMed ID: 8670784)
21. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.
Ijland SA; Jager MJ; Heijdra BM; Westphal JR; Peek R
Melanoma Res; 1999 Oct; 9(5):445-50. PubMed ID: 10596910
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.
Dong-Le Bourhis X; Lambrecht V; Boilly B
Br J Cancer; 1998; 77(3):396-403. PubMed ID: 9472634
[TBL] [Abstract][Full Text] [Related]
23. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.
Woodward JK; Elshaw SR; Murray AK; Nichols CE; Cross N; Laws D; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3144-52. PubMed ID: 12356817
[TBL] [Abstract][Full Text] [Related]
24. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1.
Falk P; Ma C; Chegini N; Holmdahl L
Scand J Clin Lab Invest; 2000 Oct; 60(6):439-47. PubMed ID: 11129059
[TBL] [Abstract][Full Text] [Related]
27. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents.
Busso N; Nicodeme E; Chesne C; Guillouzo A; Belin D; Hyafil F
Hepatology; 1994 Jul; 20(1 Pt 1):186-90. PubMed ID: 8020888
[TBL] [Abstract][Full Text] [Related]
28. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
Woodward JK; Rennie IG; Burn JL; Sisley K
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta.
Keski-Oja J; Blasi F; Leof EB; Moses HL
J Cell Biol; 1988 Feb; 106(2):451-9. PubMed ID: 3276718
[TBL] [Abstract][Full Text] [Related]
30. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
Keski-Oja J; Koli K
J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro.
Albo D; Arnoletti JP; Castiglioni A; Granick MS; Solomon MP; Rothman VL; Tuszynski GP
Biochem Biophys Res Commun; 1994 Sep; 203(2):857-65. PubMed ID: 8093068
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix degradation by cultured mesangial cells: mediators and modulators.
Baricos WH; Reed JC; Cortez SL
Exp Biol Med (Maywood); 2003 Oct; 228(9):1018-22. PubMed ID: 14530509
[TBL] [Abstract][Full Text] [Related]
33. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.
Erichsen JT; Jarvis-Evans J; Khaliq A; Boulton M
Int J Biochem Cell Biol; 2001 Mar; 33(3):237-47. PubMed ID: 11311855
[TBL] [Abstract][Full Text] [Related]
34. Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes.
Zhang T; Zhou HM; Liu YX
Mol Hum Reprod; 1997 Mar; 3(3):223-31. PubMed ID: 9237248
[TBL] [Abstract][Full Text] [Related]
35. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
[TBL] [Abstract][Full Text] [Related]
36. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
Park KW; Choi SH; Song XX; Funahashi H; Niwa K
Biol Reprod; 1999 Jul; 61(1):298-304. PubMed ID: 10377062
[TBL] [Abstract][Full Text] [Related]
37. Regulation of tissue plasminogen activator production in cultured human fetal mesangial cells.
Yoshiko B; Yamabe H; Osawa H; Okumura K
Exp Nephrol; 1998; 6(6):508-13. PubMed ID: 9807022
[TBL] [Abstract][Full Text] [Related]
38. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
39. Follicular stage-dependent regulation of rat granulosa cell plasminogen activator system by transforming growth factor-alpha in vitro.
Karakji EG; Tsang BK
Biol Reprod; 1995 Feb; 52(2):411-8. PubMed ID: 7711210
[TBL] [Abstract][Full Text] [Related]
40. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
